Envestnet Asset Management
LKFT

Envestnet Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Envestnet Asset Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,469
Closed -$331K – 4028
2022
Q4 		$331K Buy
7,469
+1,507
+25% +$63.4K ﹤0.01% 3356
2022
Q3 		$254K Buy
+5,962
New +$305K ﹤0.01% 3457
2021
Q3 		– Sell
-13,449
Closed -$927K – 3707
2021
Q2 		$927K Sell
13,449
-11,444
-46% -$873K ﹤0.01% 2586
2021
Q1 		$1.92M Sell
24,893
-9,106
-27% -$839K ﹤0.01% 1960
2020
Q4 		$3.37M Sell
33,999
-3,893
-10% -$476K ﹤0.01% 1470
2020
Q3 		$5.38M Sell
37,892
-7,134
-16% -$1.19M ﹤0.01% 1130
2020
Q2 		$8.88M Buy
45,026
+3,226
+8% +$668K 0.01% 829
2020
Q1 		$8.19M Buy
41,800
+26,234
+169% +$5.64M 0.01% 757
2019
Q4 		$3.22M Buy
15,566
+920
+6% +$170K ﹤0.01% 1350
2019
Q3 		$2.24M Buy
14,646
+1,348
+10% +$221K ﹤0.01% 1488
2019
Q2 		$1.72M Sell
13,298
-504
-4% -$59.8K ﹤0.01% 1644
2019
Q1 		$1.63M Buy
13,802
+433
+3% +$43.7K ﹤0.01% 1583
2018
Q4 		$1.23M Buy
+13,369
New +$1.36M ﹤0.01% 1607
2018
Q3 		– Sell
-1,827
Closed -$168K – 1780
2018
Q2 		$168K Hold
1,827
– – ﹤0.01% 1748
2018
Q1 		$182K Sell
1,827
-488
-21% -$52.6K ﹤0.01% 1629
2017
Q4 		$217K Buy
2,315
+573
+33% +$54.2K ﹤0.01% 1808
2017
Q3 		$177K Buy
1,742
+1,063
+157% +$92.9K ﹤0.01% 1878
2017
Q2 		$52K Buy
679
+400
+143% +$33.6K ﹤0.01% 2348
2017
Q1 		$25K Sell
279
-90
-24% -$6.48K ﹤0.01% 2624
2016
Q4 		$23K Buy
+369
New +$22.7K ﹤0.01% 2637

Other funds holding LKFT

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Envestnet Asset Management's LKFT Position: Q1 2023 in Review

Envestnet Asset Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2023, closing a stake of 7,469 shares — an estimated $331K sold.

Envestnet Asset Management first reported a position in LKFT in Q4 2016 and held it in 20 quarters. The position peaked at $8.88M in Q2 2020. 75 funds tracked by Wall St. Rank hold LKFT as of Q1 2023.

  • Envestnet Asset Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Envestnet Asset Management sold 7,469 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2023, an estimated $331K.
  • Envestnet Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2016 and held it in 20 quarters.
  • Envestnet Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $8.88M in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2023.

Based on Envestnet Asset Management's 13F filing for Q1 2023, filed 11 May 2023.